Form: Rabies post exposure risk assessment form and calendar

Public Health England

February 26
09:30 2020

Rabies post exposure risk assessment form and calendar

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email tell us what format you need. It will help us if you say what assistive technology you use.


The current lot of human rabies immunoglobulin (HRIG) in use in England is JRC19254. The potency is 167 IU/ml, vial volume 2.6 ml, and expiry date 31 March 2021.

Return completed risk assessment form to the vaccine clerk, Virus reference department (VRD) by email to or

Published 31 December 2013
Last updated 26 February 2020 +show all updates
  1. Added updated risk assessment form and updated the details of the current HRIG in use.

  2. Added new telephone number for the Rabies and Immunoglobulin service.

  3. Updated with form version 29.

  4. Updated with version 28, and details of the new batch of rabies immunoglobulin in use from 1 May 2019.

  5. Updated with form version 27.

  6. Updated with form version 26.

  7. Updated with form version 25.

  8. Updated with form version 24.

  9. Updated with form version 23.

  10. Updated with form version 22.

  11. Updated with form version 21.

  12. Updated to reflect new guidance and current vaccines and HRIG in use.

  13. Updated with v19.

  14. Updated form with v18.

  15. Updated form with v17.

  16. Updated (v16) to include ability to choose category III for primate exposures to head or neck.

  17. Updated form (version 15).

  18. Updated form (version 14), to reflect changes in rabies status of France.

  19. Updated form (version 13) for details of vaccine batch.

Related Articles


  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:

Post my comment

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: